Effects of zoledronic acid versus clodronic acid on skeletal morbidity in patients with newly diagnosed multiple myeloma (MRC Myeloma IX): secondary outcomes from a randomised controlled trial


Morgan, Gareth J., Child, J. Anthony, Gregory, Walter M., Szubert, Alex J., Cocks, Kim, Bell, Sue E., Navarro-Coy, Nuria, Drayson, Mark T., Owen, Roger G., Feyler, Sylvia, Ashcroft, A. John, Ross, Fiona M., Byrne, Jennifer, Roddie, Huw, Rudin, Claudius, Cook, Gordon, Jackson, Graham H., Wu, Ping and Davies, Faith E. (2011) Effects of zoledronic acid versus clodronic acid on skeletal morbidity in patients with newly diagnosed multiple myeloma (MRC Myeloma IX): secondary outcomes from a randomised controlled trial. The Lancet Oncology, 12, (8), 743-752. (doi:10.1016/S1470-2045(11)70157-7).

Download

Full text not available from this repository.

Item Type: Article
Digital Object Identifier (DOI): doi:10.1016/S1470-2045(11)70157-7
ISSNs: 1470-2045 (print)
Related URLs:
Subjects: Q Science > QH Natural history > QH426 Genetics
Divisions : Faculty of Medicine > Human Development and Health
ePrint ID: 337724
Accepted Date and Publication Date:
Status
August 2011Published
Date Deposited: 02 May 2012 16:09
Last Modified: 31 Mar 2016 14:27
URI: http://eprints.soton.ac.uk/id/eprint/337724

Actions (login required)

View Item View Item